J&J | La Marge Brute Sur Les Ventes



Gross Profit On Sales Changement Date
AbbVie USD 9.34B 1.36B 2025-03
Abbott USD 5.87B 50M 2025-06
Amgen USD 6.17B 624M 2025-06
AstraZeneca USD 11.98B 637M 2025-06
Baxter International USD 1.14B 283M 2025-06
Bayer EUR 6.38B 1.74B 2025-06
Becton, Dickinson and Co. USD 2.63B 377M 2025-06
Biogen USD 2.04B 238.8M 2025-06
Boston Scientific USD 3.42B 228M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
CONMED USD 188.32M 7.16M 2025-06
Cooper Companies USD 679.1M 18.9M 2025-04
Dexcom USD 688.8M 99.8M 2025-06
Edwards Lifesciences USD 1.19B 76.7M 2025-06
Eli Lilly USD 13.11B 2.61B 2025-06
Gilead Sciences USD 5.58B 453M 2025-06
GlaxoSmithKline GBP 5.82B 229M 2025-06
Globus Medical USD 1.21B 809.01M 2025-06
Hologic USD 576.6M 15.9M 2025-06
Insulet USD 452.2M 43.2M 2025-06
Integra LifeSciences USD 209.33M 5.81M 2025-06
Intuitive Surgical USD 1.62B 160.2M 2025-06
J&J USD 14.6B 816M 2025-03
Medtronic USD 5.81B 296M 2025-04
Merck USD 12.99B 224M 2025-06
Merit Medical Systems USD 184.49M 12.47M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Pfizer USD 10.88B 248M 2025-06
Regeneron Pharmaceuticals USD 3.15B 581M 2025-06
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.74B 26M 2025-06
Stryker USD 3.84B 30M 2025-06
Tandem Diabetes Care USD 125.85M 7.45M 2025-06
Teva Pharmaceutical Industries USD 2.1B 188M 2025-06
Vertex Pharmaceuticals USD 2.56B 150M 2025-06
Zimmer Biomet Holdings USD 1.32B 34.8M 2025-06
Zoetis USD 1.78B 180M 2025-06


J&J La Marge Brute Sur Les Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.